Steven Gannon - Jun 4, 2021 Form 4 Insider Report for Fusion Pharmaceuticals Inc. (FUSN)

Role
Director
Signature
/s/Maria Stahl as Attorney-in-Fact for Steve Gannon
Stock symbol
FUSN
Transactions as of
Jun 4, 2021
Transactions value $
$0
Form type
4
Date filed
6/7/2021, 04:15 PM
Previous filing
Jun 3, 2021
Next filing
Aug 17, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Option (Right to Buy) Award $0 +17K $0.00 17K Jun 4, 2021 Common Stock 17K $8.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option fully vests on the earlier of (i) June 4, 2022 or (ii) the 2022 Annual Meeting of Shareholders of Fusion Pharmaceuticals Inc.